Page last updated: 2024-10-21

phenytoin and Paraproteinemias

phenytoin has been researched along with Paraproteinemias in 1 studies

Paraproteinemias: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.

Research Excerpts

ExcerptRelevanceReference
"Phenytoin is a drug used for the treatment of different types of seizures."1.35Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda. ( Brauchli, YB; Krähenbühl, S; Scholer, A; Schwietert, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brauchli, YB1
Scholer, A1
Schwietert, M1
Krähenbühl, S1

Other Studies

1 other study available for phenytoin and Paraproteinemias

ArticleYear
Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
    Clinica chimica acta; international journal of clinical chemistry, 2008, Volume: 389, Issue:1-2

    Topics: Aged; Anticonvulsants; Automation; Epilepsy; Female; Humans; Immunoassay; Immunoglobulin M; Paraprot

2008